Travere Therapeutics, Inc. Annual Earnings Per Share, Basic in USD/shares from 2013 to 2023

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Travere Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2013 to 2023.
  • Travere Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -0.7 USD/shares, a 136% decline year-over-year.
  • Travere Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -4.55 USD/shares, a 212% decline year-over-year.
  • Travere Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -1.5 USD/shares, a 65.7% increase from 2022.
  • Travere Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.37 USD/shares, a 45.2% decline from 2021.
  • Travere Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -3.01 USD/shares, a 15.4% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$2 +$2.87 +65.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 -$4 -$1 -45.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 -$3 +$0.55 +15.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$4 $0 -2.89% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 -$3 -$1 -36.2% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$3 -$1 -64.9% Jan 1, 2018 Dec 31, 2018 10-K 2019-02-26
2017 -$2 $0 -19.4% Jan 1, 2017 Dec 31, 2017 10-K 2019-02-26
2016 -$1 -$5 -137% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-26
2015 $3.49 +$7.92 Jan 1, 2015 Dec 31, 2015 10-K/A 2018-07-06
2014 -$4 -$2 -81.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$2 Jan 1, 2013 Dec 31, 2013 10-K 2016-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.